Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy

Documenti analoghi

• Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular Dystrophy
  di: Rooney, Jachinta E., et al.
  Pubblicazione: (2012)
• Correction for Rooney et al., Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy
  Pubblicazione: (2009)
• Laminin-111 Restores Regenerative Capacity in a Mouse Model for α7 Integrin Congenital Myopathy
  di: Rooney, Jachinta E., et al.
  Pubblicazione: (2009)
• Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy
  di: Van Ry, Pam M, et al.
  Pubblicazione: (2015)
• Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy
  di: Van Ry, Pam M., et al.
  Pubblicazione: (2014)